BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31894282)

  • 21. Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.
    Hasan MK; Ghia EM; Rassenti LZ; Widhopf GF; Kipps TJ
    Leukemia; 2021 Jun; 35(6):1621-1630. PubMed ID: 33097837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
    Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
    J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression.
    Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y
    J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
    Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
    Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.
    Nomachi A; Nishita M; Inaba D; Enomoto M; Hamasaki M; Minami Y
    J Biol Chem; 2008 Oct; 283(41):27973-27981. PubMed ID: 18667433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel role of etoposide in inhibiting the migration and proliferation of small cell lung cancer and breast cancer via targeting Daam1.
    Yu X; Xu T; Su B; Zhou J; Xu B; Zhang Y; Zhu Y; Jiang N; He Z
    Biochem Pharmacol; 2023 Apr; 210():115468. PubMed ID: 36858182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
    Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
    Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
    Qi X; Okinaka Y; Nishita M; Minami Y
    Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
    Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
    Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
    Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
    Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
    Zhang C; Hu Y; Wan J; He H
    Oncol Rep; 2015 Oct; 34(4):2195-201. PubMed ID: 26259653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
    Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
    J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells.
    Yamauchi N; Otsuka M; Ishikawa T; Kakeji Y; Kikuchi A; Masuda A; Kodama Y; Minami Y; Kamizaki K
    Genes Cells; 2024 Jun; 29(6):503-511. PubMed ID: 38531660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
    Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
    Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.
    Grither WR; Baker B; Morikis VA; Ilagan MXG; Fuh KC; Longmore GD
    Mol Cancer Res; 2024 May; 22(5):495-507. PubMed ID: 38334461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma.
    Barbero G; Castro MV; Villanueva MB; Quezada MJ; Fernández NB; DeMorrow S; Lopez-Bergami P
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
    O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
    Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma.
    Lu BJ; Wang YQ; Wei XJ; Rong LQ; Wei D; Yan CM; Wang DJ; Sun JY
    Mol Med Rep; 2012 Apr; 5(4):1033-6. PubMed ID: 22293903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
    Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.